CD34+ chimerism analysis for minimal residual disease monitoring after allogeneic hematopoietic cell transplantation
Gespeichert in:
| Veröffentlicht in: | Leukemia research 2018-11, Vol.74, p.110-112 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 112 |
|---|---|
| container_issue | |
| container_start_page | 110 |
| container_title | Leukemia research |
| container_volume | 74 |
| creator | Unnikrishnan, Athira Meacham, Amy M. Goldstein, Steven S. Ta, Mai Leather, Helen L. Cogle, Christopher R. Castillo, Paul Wingard, John R. Norkin, Maxim |
| description | |
| doi_str_mv | 10.1016/j.leukres.2018.10.007 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2130805307</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0145212618304417</els_id><sourcerecordid>2130805307</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-8353193a5a08aa4909f01dff90665d2bf647fd44d87eefe20c4d701a1599a7b93</originalsourceid><addsrcrecordid>eNqFUE2PFCEQJUbjjqs_QcPRxPRYNE13czJm_Ew28aJnwkCxy0jDCPQm--9lnNGrp6p6eVWv3iPkJYMtAza-PWwDrj8zlm0PbG7YFmB6RDZsnngnZi4ekw2wQXQ968cr8qyUAwAIyeRTcsVhACZ6tiF194EPb6i58wtmXxaqow4PxRfqUqaLj37RgTYZb9fWWF9QF6RLir6m7OMt1a5ipjqEdIsRvaF3uOiajsljbZPBEGjNOpZj0LHq6lN8Tp44HQq-uNRr8uPTx--7L93Nt89fd-9vOsNHUbtmgjPJtdAwaz1IkA6YdU7COArb7904TM4Og50nRIc9mMFOwDQTUuppL_k1eX2-e8zp14qlqsWX00M6YlqL6hmHGQSHqVHFmWpyKiWjU8fcrOcHxUCdAlcHdQlcnQI_wfBn79VFYt0vaP9t_U24Ed6dCdiM3nvMqhiP0aD1GU1VNvn_SPwG9PeWfg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2130805307</pqid></control><display><type>article</type><title>CD34+ chimerism analysis for minimal residual disease monitoring after allogeneic hematopoietic cell transplantation</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Unnikrishnan, Athira ; Meacham, Amy M. ; Goldstein, Steven S. ; Ta, Mai ; Leather, Helen L. ; Cogle, Christopher R. ; Castillo, Paul ; Wingard, John R. ; Norkin, Maxim</creator><creatorcontrib>Unnikrishnan, Athira ; Meacham, Amy M. ; Goldstein, Steven S. ; Ta, Mai ; Leather, Helen L. ; Cogle, Christopher R. ; Castillo, Paul ; Wingard, John R. ; Norkin, Maxim</creatorcontrib><identifier>ISSN: 0145-2126</identifier><identifier>EISSN: 1873-5835</identifier><identifier>DOI: 10.1016/j.leukres.2018.10.007</identifier><identifier>PMID: 30401521</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Allografts ; Antigens, CD34 - blood ; Female ; Follow-Up Studies ; Hematopoietic Stem Cell Transplantation ; Humans ; Leukemia, Myeloid, Acute - blood ; Leukemia, Myeloid, Acute - therapy ; Male ; Myelodysplastic Syndromes - blood ; Myelodysplastic Syndromes - therapy ; Neoplasm, Residual ; Prospective Studies ; Transplantation Chimera - blood</subject><ispartof>Leukemia research, 2018-11, Vol.74, p.110-112</ispartof><rights>2018 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-8353193a5a08aa4909f01dff90665d2bf647fd44d87eefe20c4d701a1599a7b93</citedby><cites>FETCH-LOGICAL-c365t-8353193a5a08aa4909f01dff90665d2bf647fd44d87eefe20c4d701a1599a7b93</cites><orcidid>0000-0001-6048-7760</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.leukres.2018.10.007$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30401521$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Unnikrishnan, Athira</creatorcontrib><creatorcontrib>Meacham, Amy M.</creatorcontrib><creatorcontrib>Goldstein, Steven S.</creatorcontrib><creatorcontrib>Ta, Mai</creatorcontrib><creatorcontrib>Leather, Helen L.</creatorcontrib><creatorcontrib>Cogle, Christopher R.</creatorcontrib><creatorcontrib>Castillo, Paul</creatorcontrib><creatorcontrib>Wingard, John R.</creatorcontrib><creatorcontrib>Norkin, Maxim</creatorcontrib><title>CD34+ chimerism analysis for minimal residual disease monitoring after allogeneic hematopoietic cell transplantation</title><title>Leukemia research</title><addtitle>Leuk Res</addtitle><subject>Allografts</subject><subject>Antigens, CD34 - blood</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Hematopoietic Stem Cell Transplantation</subject><subject>Humans</subject><subject>Leukemia, Myeloid, Acute - blood</subject><subject>Leukemia, Myeloid, Acute - therapy</subject><subject>Male</subject><subject>Myelodysplastic Syndromes - blood</subject><subject>Myelodysplastic Syndromes - therapy</subject><subject>Neoplasm, Residual</subject><subject>Prospective Studies</subject><subject>Transplantation Chimera - blood</subject><issn>0145-2126</issn><issn>1873-5835</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUE2PFCEQJUbjjqs_QcPRxPRYNE13czJm_Ew28aJnwkCxy0jDCPQm--9lnNGrp6p6eVWv3iPkJYMtAza-PWwDrj8zlm0PbG7YFmB6RDZsnngnZi4ekw2wQXQ968cr8qyUAwAIyeRTcsVhACZ6tiF194EPb6i58wtmXxaqow4PxRfqUqaLj37RgTYZb9fWWF9QF6RLir6m7OMt1a5ipjqEdIsRvaF3uOiajsljbZPBEGjNOpZj0LHq6lN8Tp44HQq-uNRr8uPTx--7L93Nt89fd-9vOsNHUbtmgjPJtdAwaz1IkA6YdU7COArb7904TM4Og50nRIc9mMFOwDQTUuppL_k1eX2-e8zp14qlqsWX00M6YlqL6hmHGQSHqVHFmWpyKiWjU8fcrOcHxUCdAlcHdQlcnQI_wfBn79VFYt0vaP9t_U24Ed6dCdiM3nvMqhiP0aD1GU1VNvn_SPwG9PeWfg</recordid><startdate>201811</startdate><enddate>201811</enddate><creator>Unnikrishnan, Athira</creator><creator>Meacham, Amy M.</creator><creator>Goldstein, Steven S.</creator><creator>Ta, Mai</creator><creator>Leather, Helen L.</creator><creator>Cogle, Christopher R.</creator><creator>Castillo, Paul</creator><creator>Wingard, John R.</creator><creator>Norkin, Maxim</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6048-7760</orcidid></search><sort><creationdate>201811</creationdate><title>CD34+ chimerism analysis for minimal residual disease monitoring after allogeneic hematopoietic cell transplantation</title><author>Unnikrishnan, Athira ; Meacham, Amy M. ; Goldstein, Steven S. ; Ta, Mai ; Leather, Helen L. ; Cogle, Christopher R. ; Castillo, Paul ; Wingard, John R. ; Norkin, Maxim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-8353193a5a08aa4909f01dff90665d2bf647fd44d87eefe20c4d701a1599a7b93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Allografts</topic><topic>Antigens, CD34 - blood</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Hematopoietic Stem Cell Transplantation</topic><topic>Humans</topic><topic>Leukemia, Myeloid, Acute - blood</topic><topic>Leukemia, Myeloid, Acute - therapy</topic><topic>Male</topic><topic>Myelodysplastic Syndromes - blood</topic><topic>Myelodysplastic Syndromes - therapy</topic><topic>Neoplasm, Residual</topic><topic>Prospective Studies</topic><topic>Transplantation Chimera - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Unnikrishnan, Athira</creatorcontrib><creatorcontrib>Meacham, Amy M.</creatorcontrib><creatorcontrib>Goldstein, Steven S.</creatorcontrib><creatorcontrib>Ta, Mai</creatorcontrib><creatorcontrib>Leather, Helen L.</creatorcontrib><creatorcontrib>Cogle, Christopher R.</creatorcontrib><creatorcontrib>Castillo, Paul</creatorcontrib><creatorcontrib>Wingard, John R.</creatorcontrib><creatorcontrib>Norkin, Maxim</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Leukemia research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Unnikrishnan, Athira</au><au>Meacham, Amy M.</au><au>Goldstein, Steven S.</au><au>Ta, Mai</au><au>Leather, Helen L.</au><au>Cogle, Christopher R.</au><au>Castillo, Paul</au><au>Wingard, John R.</au><au>Norkin, Maxim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CD34+ chimerism analysis for minimal residual disease monitoring after allogeneic hematopoietic cell transplantation</atitle><jtitle>Leukemia research</jtitle><addtitle>Leuk Res</addtitle><date>2018-11</date><risdate>2018</risdate><volume>74</volume><spage>110</spage><epage>112</epage><pages>110-112</pages><issn>0145-2126</issn><eissn>1873-5835</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>30401521</pmid><doi>10.1016/j.leukres.2018.10.007</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0001-6048-7760</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0145-2126 |
| ispartof | Leukemia research, 2018-11, Vol.74, p.110-112 |
| issn | 0145-2126 1873-5835 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2130805307 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Allografts Antigens, CD34 - blood Female Follow-Up Studies Hematopoietic Stem Cell Transplantation Humans Leukemia, Myeloid, Acute - blood Leukemia, Myeloid, Acute - therapy Male Myelodysplastic Syndromes - blood Myelodysplastic Syndromes - therapy Neoplasm, Residual Prospective Studies Transplantation Chimera - blood |
| title | CD34+ chimerism analysis for minimal residual disease monitoring after allogeneic hematopoietic cell transplantation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T19%3A08%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CD34+%20chimerism%20analysis%20for%20minimal%20residual%20disease%20monitoring%20after%20allogeneic%20hematopoietic%20cell%20transplantation&rft.jtitle=Leukemia%20research&rft.au=Unnikrishnan,%20Athira&rft.date=2018-11&rft.volume=74&rft.spage=110&rft.epage=112&rft.pages=110-112&rft.issn=0145-2126&rft.eissn=1873-5835&rft_id=info:doi/10.1016/j.leukres.2018.10.007&rft_dat=%3Cproquest_cross%3E2130805307%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2130805307&rft_id=info:pmid/30401521&rft_els_id=S0145212618304417&rfr_iscdi=true |